Universita' Degli Studi Di Roma La Sapienza — Clinical Trial Site

30 Registered trials

11 Currently recruiting

Organisation

Universita' Degli Studi Di Roma La Sapienza

Location

Rome, Italy

Identifier

ORG-100011204

Address

Viale Regina Elena 324, 00161, Italy

Departments

4107: Dipartimento di medicina translazione e di precisione sez Ematologia
AO S. Andrea - Centro Neurologico Terapie Sperimentali - UOC di Neurologia
AO S. Andrea - UOC Neurologia
Assistant Professor cardiovalurar sciences, Sapienza university of Roma
Department of Cellular Biotechnologies and Hematology
Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences
Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinol
Department of Ophthalmology
Department of Translational and Precision Medicine
Dip. Scienze Radiologiche, Radioterapiche ed Oncologiche
Dipartimento di medicina traslazionale e di precisione
Dipartimento di NEUROSCIENZE UMANE
Dipartimento Materno Infantile e di Scienze Urologiche
Dipartimento Medicina Interna, Scienze Endocrino-metaboliche e Malattie Infettive
Hematology
Hematology Department
Maternal Science
Nefrologia
Neuroscienze Umane
Oncoematologia pediatrica Ospedale “Bambino Gesù"
Oncology
Pediatric Gastroenterology and Liver Unit Maternal and Child Health Department
Radiotherapy
UOC Dermatologia
UOC Dermatologia Universitaria
UOC Ginecologia Chirurgica e Oncologica
UOC Oncologia Medica A
Urology

Clinical trials at this site (30)

Search interface

A PROJECT FOR TWO MULTICENTRE, PROSPECTIVE OPEN LABEL RANDOMIZED CLINICAL STUDIES TO EVALUATE THE EFFECT OF TARGETED THERAPY BASED ON KIDNEY… Pending

2024-517861-18-00 Idiopathic IgA nephropathy (IgAN) 5
A phase III study on using immunotherapy and radiotherapy to treat limited spread of Head and Neck Cancer Recruiting

2023-504478-39-00 Squamous cell carcinoma of head and neck 5 2025-05-23
Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants from Approximately 2 Months of Age Recruiting

2023-507600-32-00 Pneumococcal Immunization 5 2025-05-22
BEAMION Lung-2: A study to test whether zongertinib (BI 1810631) helps people with advanced non-small cell lung cancer with HER2 mutations c… Recruiting

2023-504308-27-00 non-squamous non-small cell lung cancer 5 2024-06-06
Study of Trastuzumab Deruxtecan with Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer… Recruiting

2024-516982-35-00 Ovarian Cancer 5 2025-09-11
A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 2 trial to evaluate the efficacy and safety of BP1.7881 in… Recruiting

2023-508949-40-00 Eosinophilic esophagitis 4 2024-11-29
Surgical treatment with or without apalutamide in subjects with high risk prostate cancer who are candidates for radical prostatectomy and s… Recruiting

2024-515049-41-00 metastatic prostate cancer 4 2024-07-12
Lomustine with or without a second round of brain radiation for the reappearance of glioblastoma Recruiting

2023-505267-36-00 Glioblastoma 5 2024-03-15
Randomized trial comparing efficacy and safety of initial triple therapy including parenteral treprostinil to initial double oral therapy in… Recruiting

2023-504351-26-01 Pulmonary arterial hypertension (group I) 11 2023-12-06
"APalutamide and stEReotactic body radiation therapy for low burden metastatic hormone senSItive prostate cancer, a rANdomized trial -PERSIA… Recruiting

2022-501894-37-00 prostate cancer 4 2023-03-02
Riluzole in spinocerebellar ataxia type 7 Recruiting

2024-518962-29-00 Spinocerebellar ataxia type 7 (SCA7) 4 2021-12-07
Bacille Calmette-Guérin (BCG) vaccine in Radiologically Isolated Syndrome (RIS) Recruiting

2024-518901-16-00 RIS (Radiologically Isolated Syndrome) 4 2019-07-29
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis Ended

2024-512676-36-00 Langerhans Cell Histiocytosis 10 2024-10-09
LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended

2022-501419-15-00 Atrial Fibrillation 5 2023-08-23
A CLINICAL TRIAL TO CONFIRM THE EFFICACY OF OLAPARIB IN COMBINATION WITH BEVACIZUMAB, ADMINISTERED AS MAINTENANCE THERAPY AFTER A FRONTLINE … Ended

2022-502242-27-00 Patients with a confirmation of advanced, high grade ep 6 2023-06-16
A Phase 4, Multi-centre, Randomized, Evaluator-blinded, Active-controlled Study to Determine the Incidence of Squamous Cell Carcinoma and Ev… Ended

2024-514394-22-00 Actinic Keratosis 6 2022-10-24
A Phase 3 Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant Ended

2023-508897-27-00 Multiple Myeloma 5 2022-04-28
A Study to Evaluate the Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Profiles of CGT9486 in subjects with Advanced Systemic Mastocy… Ended

2024-511407-42-00 Advanced Systemic Mastocytosis 4 2022-01-10
Clinical study of ibrutinib and rituximab in untreated marginal zone lymphomas Ended

2023-507886-25-00 Previously untreated and symptomatic patients with hist 4 2019-09-27
Extended Access of Momelotinib for Subjects with Myelofibrosis Ended

2023-508018-41-00 Primary Myelofibrosis (PMF), Post-polycythemia Vera or 4 2018-07-27
A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study Ended

2023-503803-27-00 B-cell non-Hodgkin's lymphoma and cGVHD 5 2013-10-25
A study to test long-term treatment with spesolimab in people with a skin condition disease called hidradenitis suppurativa (HS) who took pa… Ended

2023-508377-82-00 Hidradenitis Suppurativa (HS) 10 2024-06-27
A study to test whether spesolimab helps people with a skin disease called hidradenitis suppurativa Ended

2022-501074-19-00 Hidradenitis suppurativa 10 2023-10-13
A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adult… Ended

2022-502552-31-00 Relapsing Forms of Multiple Sclerosis 4 2023-10-03